Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs
May 1, 2016, 00:00
10.1016/j.jval.2016.03.220
https://www.valueinhealthjournal.com/article/S1098-3015(16)00288-6/fulltext
Title :
Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00288-6&doi=10.1016/j.jval.2016.03.220
First page :
A69
Section Title :
Neurological Disorders - Health Care Use & Policy Studies
Open access? :
No
Section Order :
1572